LianBio is a biopharmaceutical company that designs and provides innovative drugs and treatments for oncology and cardiology diseases. The company aims to accelerate the development and expand the availability of medicines to help patients with transformative mechanisms and precision-based therapeutics.
|Employees (est.) (Sept 2021)||38||(+23%)|
LianBio total Funding
LianBio latest funding size
Time since last funding
|a year ago|
|Wellington Management, Viking Global Investors, Casdin Capital, Vida Ventures, Venrock Healthcare Capital Partners, RA Capital, Logos Capital, CMG-SDIC Capital, Farallon, China Merchant Capital, Sphera Healthcare, Tyborne Capital Management, Pfizer Inc|
When was LianBio founded?
LianBio was founded in 2019.
Who are LianBio key executives?
LianBio's key executives are Debra Yu, Jing Ji and Nathan Chen.
How many employees does LianBio have?
LianBio has 38 employees.
Who are LianBio competitors?
Competitors of LianBio include SHINKEI Therapeutics, Yamo Pharmaceuticals and Biodol Therapeutics.
Where is LianBio headquarters?
LianBio headquarters is located at 1155 Fangdian Rd, Shi Ji Gong Yuan, Pudong Xinqu, Shanghai.
Where are LianBio offices?
LianBio has offices in Shanghai and Princeton.
How many offices does LianBio have?
LianBio has 2 offices.
Receive alerts for 300+ data fields across thousands of companies